Endovascular Treatment of Right Heart Masses Utilizing the AngioVac System: A 6-Year Single-Center Observational Study

Table 3

Postoperative variables.

Variable	n (%) or median (IQR)
Operative success	16 (94.1)
Survival	17 (100.0)
Survival to discharge	14 (82.4)
30-day survival	13 (76.5)
One-year survival	4 (23.5)
Average LOS	8.07 (3.0–10.0)
Need for tPA	0 (0.0)
Need for transfusion	5 (29.4)
Need for hemodialysis	0 (0.0)
LVEF	57.5 (54.25–62.75)
Side effects
Hematomas	3 (17.6)
Shock	1 (5.9)
Hypotension	6 (35.3)
Vasopressor use	2 (11.8)
Hemoglobin	8.7 (7.4–9.5)
Creatinine	1.09 (0.63–1.15)

^∗Nine patients missing postoperative LVEF. ^∗∗Other side effects were worsening tachycardia, PE, mycotic aneurysm, intraoperative SVT, need for intubation (2), and need for the IVC filter. IQR: interquartile range; IVC: inferior vena cava; LOS: length of stay; LVEF: left ventricular ejection fraction; PE: pulmonary embolism; SVT: supraventricular tachycardia; tPA: tissue plasminogen activator.